Tolerances for Residues of New Animal Drugs in Food; Apramycin

Краткое содержание

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADA's) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA's provide for revised tolerances for total residues of apramycin (i.e., the safe concentration) in edible swine tissues.